Hanna Niehues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hanna Niehues has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Ellen H. van Den Bogaard
Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
10 shared publications - Patrick L. J. M. Zeeuwen
Department of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
8 shared publications - Gijs Rikken
Dermatology, Radboudumc, Nijmegen, Netherlands
5 shared publications - Joost Schalkwijk
Department of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
5 shared publications - Diana Rodijk-Olthuis
Department of Dermatology, Radboud University Medical Center Radboud Institute for Molecular Life Sciences (RIMLS) Nijmegen The Netherlands
4 shared publications - Jos P. H. Smits
Department of Dermatology, Radboud University Medical Center, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Dermatology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
4 shared publications
Latest Publications
- Open Access
- 8 March 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1
Correction: Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes
- 8 March 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1
Open AccessCorrection: Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes
- 18 January 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-6
Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes
We have recently shown that fluoxetine (FX) suppressed polyinosinic-polycytidylic acid-induced inflammatory response and endothelin release in human epidermal keratinocytes, via the indirect inhibition of the phosphoinositide 3-kinase (PI3K)-pathway. Because PI3K-signaling is a positive regulator of the proliferation, in the current, highly focused follow-up study, we assessed the effects of FX (14 µM) on the proliferation and differentiation of human epidermal keratinocytes. We found that FX exerted anti-proliferative actions in 2D cultures (HaCaT and primary human epidermal keratinocytes [NHEKs]; 48- and 72-h; CyQUANT-assay) as well as in 3D reconstructed epidermal equivalents (48-h; Ki-67 immunohistochemistry). Importantly, FX did not influence epidermal thickness (hematoxylin-eosin staining), and it did not have a major impact on the differentiation-associated alteration of the gene expression pattern (24-h treatments; RNA-Seq). Moreover, neither keratin (K)-1, nor K10 expression was altered by FX in NHEKs (RT-qPCR) or in 3D epidermal equivalents (semi-quantitative immunohistomorphometry). FX did not influence differentiation-induced up-regulation of occludin (RT-qPCR; NHEKs), and did not alter differentiation-associated barrier forming capacity of epidermal keratinocytes (electrical impedance; Lucifer Yellow penetration assay). Our data indicate that, besides the previously reported combined anti-inflammatory and putative anti-pruritic effects, FX may also suppress proliferation of human epidermal keratinocytes without impairing their differentiation and barrier-forming capacity.
- 18 January 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-6
Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes
We have recently shown that fluoxetine (FX) suppressed polyinosinic-polycytidylic acid-induced inflammatory response and endothelin release in human epidermal keratinocytes, via the indirect inhibition of the phosphoinositide 3-kinase (PI3K)-pathway. Because PI3K-signaling is a positive regulator of the proliferation, in the current, highly focused follow-up study, we assessed the effects of FX (14 µM) on the proliferation and differentiation of human epidermal keratinocytes. We found that FX exerted anti-proliferative actions in 2D cultures (HaCaT and primary human epidermal keratinocytes [NHEKs]; 48- and 72-h; CyQUANT-assay) as well as in 3D reconstructed epidermal equivalents (48-h; Ki-67 immunohistochemistry). Importantly, FX did not influence epidermal thickness (hematoxylin-eosin staining), and it did not have a major impact on the differentiation-associated alteration of the gene expression pattern (24-h treatments; RNA-Seq). Moreover, neither keratin (K)-1, nor K10 expression was altered by FX in NHEKs (RT-qPCR) or in 3D epidermal equivalents (semi-quantitative immunohistomorphometry). FX did not influence differentiation-induced up-regulation of occludin (RT-qPCR; NHEKs), and did not alter differentiation-associated barrier forming capacity of epidermal keratinocytes (electrical impedance; Lucifer Yellow penetration assay). Our data indicate that, besides the previously reported combined anti-inflammatory and putative anti-pruritic effects, FX may also suppress proliferation of human epidermal keratinocytes without impairing their differentiation and barrier-forming capacity.
- Open Access
- 7 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1520-1528.e5
Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes
- 7 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1520-1528.e5
Open AccessInvestigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes
- Open Access
- 15 February 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1498-1508.e7
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins
- 15 February 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1498-1508.e7
Open AccessCYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins
- 23 September 2022
- Published by Morressier GmbH
ESDR172 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins
Late cornified envelope (LCE) proteins are small cationic epidermal proteins with antimicrobial properties, and the combined deletion of LCE3B an | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR172 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins
Late cornified envelope (LCE) proteins are small cationic epidermal proteins with antimicrobial properties, and the combined deletion of LCE3B an | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR195 - Untangling the complex cytokine milieu in psoriasis and atopic dermatitis through organotypic epidermal models
In psoriasis (PSO) and atopic dermatitis (AD), the complex inflammatory milieu drives epidermal disease hallmarks that are associated to skin inf | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR195 - Untangling the complex cytokine milieu in psoriasis and atopic dermatitis through organotypic epidermal models
In psoriasis (PSO) and atopic dermatitis (AD), the complex inflammatory milieu drives epidermal disease hallmarks that are associated to skin inf | POSTER
- 23 September 2022
- Published by Morressier GmbH
E2BRN009 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins
E2BRN009 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins | POSTER
- 23 September 2022
- Published by Morressier GmbH
E2BRN009 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins
E2BRN009 - CYSRT1: an antimicrobial epidermal protein that interacts with late cornified envelope (LCE) proteins | POSTER
- Open Access
- 1 July 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (7) , 1947-1955.e6
Antimicrobial Late Cornified Envelope Proteins: The Psoriasis Risk Factor Deletion of LCE3B/C Genes Affects Microbiota Composition
- 1 July 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (7) , 1947-1955.e6
Open AccessAntimicrobial Late Cornified Envelope Proteins: The Psoriasis Risk Factor Deletion of LCE3B/C Genes Affects Microbiota Composition
- Open Access
- 22 October 2021
- Published by Elsevier in JID Innovations
- Vol. 2 (1) , 100066
Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
- 22 October 2021
- Published by Elsevier in JID Innovations
- Vol. 2 (1) , 100066
Open AccessIdentification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , S168
120 Identification of keratinocyte mitogens: implications for hyperproliferation in psoriasis and atopic dermatitis
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , S168
120 Identification of keratinocyte mitogens: implications for hyperproliferation in psoriasis and atopic dermatitis